BIOMAT Database Logo BIOMAT Database Logo

[Clinical study of a new product with hypotensive action: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride]. 1973

E Novelli, and A Grillo

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001161 Arteriosclerosis Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries. Arterioscleroses

Related Publications

E Novelli, and A Grillo
[Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
June 1970, La Clinica terapeutica,
E Novelli, and A Grillo
[Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
December 1970, La Clinica terapeutica,
E Novelli, and A Grillo
Mechanism of hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155) in the cat.
April 1968, Journal of pharmaceutical sciences,
E Novelli, and A Grillo
[Central effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
September 1968, Arzneimittel-Forschung,
E Novelli, and A Grillo
[Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
August 1966, Arzneimittel-Forschung,
E Novelli, and A Grillo
Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.
October 1967, European journal of pharmacology,
E Novelli, and A Grillo
[On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
May 1969, Medizinische Klinik,
E Novelli, and A Grillo
Sleep produced by clonidine (2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride).
December 1971, British journal of pharmacology,
E Novelli, and A Grillo
[Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride].
August 1966, Arzneimittel-Forschung,
E Novelli, and A Grillo
[Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride on adrenergic receptors].
June 1970, Revista espanola de fisiologia,
Copied contents to your clipboard!